← Leaderboards
Stanislaw Pikul
Oncoarendi Therapeutics, Llc
$112,500
Attributed
$225,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$225,000 · 1
By mechanism
R44$225,000 · 1
Top collaborators
- Reynold Alexander Panettieri1 shared
Most similar at Oncoarendi Therapeutics, Llc
Same institution · by research overlap
- Adam Golebiowski$1,060,293
- Pawel Dobrzanski$237,200
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteAdherenceAdrenal Cortex HormonesAdverse EffectsAffectAgonistAirway HyperresponsivenessAmericanAnimal ModelAspergillus FumigatusAsthmaAsthmaticAsthmatic PatientBinding ProteinsBiologicalBiological AvailabilityBiological ProductsBiopsyBreathingCanis FamiliarisCellsCessation Of LifeCharacteristicsAcidic Mammalian Chitinase